0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > BAFF

BAFF

BAFF Molecule Information

Name:B-cell-activating factor/B lymphocyte stimulator
Target Synonym:TALL-1?BAFF?B-cell-activating factor?Tumor necrosis factor ligand superfamily member 13B?Tumor necrosis factor ligand superfamily member 13b, membrane form?TNFSF13B?TNF- and APOL-related leukocyte expressed ligand 1?BLyS?BLYS?TALL1?TNFSF20?BAFF ?Tumor nec
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:11
Lastest Research Phase:Approved

BAFF Protein Product ListCompare or Buy

Cat. No. Species Product Description Structure Purity Feature
BAF-M521y Mouse Mouse BAFF / TNFSF13B / CD257 Protein, Tag Free
BAF-M521y-structure
BAF-M521y-sds
BAF-M521y-elisa_1
BAF-M5257 Mouse Mouse BAFF / TNFSF13B / CD257 Protein, Mouse IgG2a Fc Tag, low endotoxin
BAF-M5257-structure
BAF-M5257-sds
BAF-M5257-elisa_1
BAF-H82F3 Human Biotinylated Human BAFF / TNFSF13B / CD257 Protein, Avitag™,Fc Tag
BAF-H82F3-structure
BAF-H82F3-sds
BAF-H82F3-elisa_1
BAF-H82Q2 Human Biotinylated Human BAFF / TNFSF13B / CD257 Protein, His,Avitag™
BAF-H82Q2-structure
BAF-H82Q2-sds
BAF-H82Q2-elisa_1
BAF-HF268 Human FITC-Labeled Human BAFF / TNFSF13B / CD257 Protein, Fc Tag
BAF-HF268-structure
BAF-HF268-sds
BAF-HF268-elisa_1
BAF-H5248 Human Human BAFF / TNFSF13B / CD257 Protein, His Tag
BAF-H5248-structure
BAF-H5248-sds
BAF-H5248-elisa_1
BAF-H4268 Human Human BAFF / TNFSF13B / CD257 Protein, Fc Tag
BAF-H4268-structure
BAF-H4268-sds
BAF-H4268-elisa_1
BAF-H4218 Human Human BAFF / TNFSF13B / CD257 Protein, Tag Free
BAF-H4218-structure
BAF-H4218-sds

BAFF Molecule Synonym Name

TNFSF13B,BAFF,BLYS,CD257,DTL,TALL-1,TALL1,THANK,TNFSF20,ZTNF4

BAFF Molecule Background

B-cell activating factor (BAFF) is also known as tumor necrosis factor ligand superfamily member 13B , TNFSF13B, BAFF, B Lymphocyte Stimulator (BLyS) , cluster of differentiation 257 (CD257), DTL, TNF- and APOL-related leukocyte expressed ligand (TALL-1), THANK, TNFSF20, ZTNF4, and is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for receptors TNFRSF13B/TACI, TNFRSF17/BCMA, and TNFRSF13C/BAFFR. This cytokine is expressed in B cell lineage cells, and acts as a potent B cell activator. It has been also shown to play an important role in the proliferation and differentiation of B cells. It is expressed as transmembrane protein on various cell types including monocytes, dendritic cells and bone marrow stromal cells. BAFF is the natural ligand of three unusual tumor necrosis factor receptors named BAFF-R, TACI, and BCMA, all of which have differing binding affinities for it. These receptors are expressed mainly on mature B lymphocytes (TACI is also found on a subset of T-cells and BCMA on plasma cells). TACI binds worst since its affinity is higher for a protein similar to BAFF, called a proliferation-inducing ligand (APRIL). BCMA displays an intermediate binding phenotype and will work with either BAFF or APRIL to varying degrees. Signaling through BAFF-R and BCMA stimulates B lymphocytes to undergo proliferation and to counter apoptosis. All these ligands act as heterotrimers (i.e. three of the same molecule) interacting with heterotrimeric receptors, although BAFF has been known to be active as either a hetero- or homotrimer. BAFF acts as a potent B cell activator and has been shown to play an important role in the proliferation and differentiation of B cells.

BAFF Related Molecule

BAFF Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Belimumab HGS-1006; GSK-1550188; BmAb,HGS1006; GSK1550188 Approved GlaxoSmithKline BENLYSTA fda Systemic lupus erythematosus HUMAN GENOME SCIENCES INC. 2011-03-09 Systemic lupus erythematosus Details

BAFF Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Tibulizumab (Eli Lilly) Phase Ⅰ Lilly Sjoegren's syndrome Details
hCBE-11 hCBE-11 Phase Ⅰ Biogen Solid tumours Details
MEDI-0700 MEDI-0700 Phase Ⅰ MedImmune Systemic lupus erythematosus Details
Mitumprotimut T Phase Ⅲ MMRGlobal Follicular lymphoma, Non-Hodgkin's lymphoma (NHL) Details
UBP-1213 UBP-1213 Phase Ⅰ Wuhan Huaxin Kangyuan Biomedicine (Hubei), Shanghai Junshi Biosciences Systemic lupus erythematosus Details
Blisibimod A-623; AMG-623,A623,AMG623 Phase Ⅲ Anthera, Zenyaku Kogyo Systemic lupus erythematosus Details
Tabalumab LY-2127399 Phase Ⅲ Lilly Renal failure, Systemic lupus erythematosus, Multiple myeloma (MM), Multiple sclerosis (MS), Rheumatoid arthritis (RA) Details
RCT-18 RCT-18; RC-18 Phase Ⅲ Remegen Systemic lupus erythematosus, Rheumatoid arthritis (RA) Details
Atacicept TACI-Ig Phase Ⅲ ZymoGenetics, Merck Serono Chronic lymphocytic leukemia (CLL), Lupus nephritis, Multiple myeloma (MM), Systemic lupus erythematosus, Multiple sclerosis (MS), Rheumatoid arthritis (RA), Non-Hodgkin's lymphoma (NHL) Details
AMG-570 AMG-570  Phase Ⅰ Amgen, AstraZeneca Systemic lupus erythematosus Details
BAFF/IL-17 bispecific antibody Phase Ⅰ Lilly Immunological disorders Details

This web search service is supported by Google Inc.

totop